about
DOCK8 deficiency impairs CD8 T cell survival and function in humans and miceMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsThe transporter associated with antigen processing: function and implications in human diseasesMolecular studies and NK cell function of a new case of TAP2 homozygous human deficiencyConstitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathwayKnow Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis.PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing.Clinical and immunological aspects of HLA class I deficiency.Immunity to microbes: lessons from primary immunodeficiencies.Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.Regulation of immunity in bronchiectasis.Characterization and allelic variation of the transporters associated with antigen processing (TAP) genes in the domestic dog (Canis lupus familiaris).Generation of MHC class I ligands in the secretory and vesicular pathways.Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation?Severe combined immunodeficiences: new and old scenarios.Clinical Role of Human Leukocyte Antigen in Health and Disease.Periodontal and other oral manifestations of immunodeficiency diseases.Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.The changing face of polyarteritis nodosa and necrotizing vasculitis.Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).Immune regulation in idiopathic bronchiectasis.The immune response and its therapeutic modulation in bronchiectasis.Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline.Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency.Clinical and immunological remarks about TAP deficiency.IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis.Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires.Transporter associated with antigen processing deficiency syndrome: case report of an adolescent with chronic perforated granulomatous skin lesions due to TAP2 mutation.A novel spontaneous mutation in the TAP2 gene unravels its role in macrophage survival.Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis.
P2860
Q24293628-A4762EE7-8E32-4472-B671-6236EF2DD998Q26866479-DE1A50FB-48C7-4069-9CEE-C9949F102F6DQ28214433-9F106307-7B8B-4480-8F08-29EAB00EC266Q28347602-32244AE0-296B-416D-A8A9-5F5BF7C77847Q28587068-F51D2150-ED36-400B-BF6D-2591A99874F6Q30413217-8655E736-F7E4-4C5D-BF8F-535437DBDA09Q34536026-681DE1D1-A02C-4123-B3DD-DA4C07919949Q34882801-B22AE51F-BE34-4AA7-84F0-6A6FFB5ABE5CQ36222638-B20D50CF-71EA-49E0-AE7E-893E90723C4BQ36729350-C3C0AA6F-C4CB-4B87-912C-5517E21C85DAQ36830203-473851E4-9F0C-4B1E-84FD-8B07366D0290Q37209962-76831956-62B8-415B-90FD-420133EF81A3Q37356104-E893282E-440C-4A46-8D34-EFE03982E951Q37851046-6054353A-63C6-4FD3-8528-40452739C861Q37923703-D922A134-ED06-4291-B106-292EA3348276Q37976472-91DCC0A3-6E62-457C-9D77-A6B8BE276486Q38534421-9E03F474-FD72-44BF-B27C-742757543623Q38954801-367076AE-FD68-425F-ACA1-63ED53BD8F0DQ38982760-F39483EA-8274-41B3-9AED-E59D9AE34C26Q39296684-CDC2B230-D817-4602-B1C9-9BB511604BDEQ39377200-B64A43F7-A2C3-4052-A12F-1126ACC9800AQ40201364-D7D30507-BDCB-468E-ADD7-08708E92F79EQ40724742-336F01A7-357F-4112-8E6E-5689FF5D1DDCQ42283039-2988E5B7-4716-428E-A113-D5A1F593FA41Q42418090-56B823C9-27DE-470C-829F-8830F844C61FQ42728692-01D2BEA0-CC4B-4A83-BACA-FC0BE3F2C59EQ43006622-059B2483-C624-47CA-BECC-6555516183CCQ43235861-0DC4EF03-23B2-4AA3-B300-16E58FC5486CQ44944703-E8D0E455-5A29-42BE-BE48-7FD8B1CA4473Q46383217-CA9A6158-CD55-4257-B0C5-A0CEEE472CDBQ51004414-C1A9DE6D-01C8-4F16-A0A1-BEB1161A00BBQ51319062-9AE483BF-FD94-419A-96E5-782B52A92E58Q54548574-CC3973F4-6FAA-4C7B-96DF-31EE97A333BAQ54633741-B076DA02-9C28-463B-8DC0-C7B7B767CC6B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
TAP deficiency syndrome.
@ast
TAP deficiency syndrome.
@en
type
label
TAP deficiency syndrome.
@ast
TAP deficiency syndrome.
@en
prefLabel
TAP deficiency syndrome.
@ast
TAP deficiency syndrome.
@en
P2093
P2860
P1476
TAP deficiency syndrome.
@en
P2093
H T Moins-Teisserenc
J Trowsdale
S D Gadola
P2860
P304
P356
10.1046/J.1365-2249.2000.01264.X
P577
2000-08-01T00:00:00Z